Skin cancer vaccine FDA approved by December 31, 2027? leads at 72%. Moderate consensus — room for value on contrarian bets.
| # | Outcome | Probability | If Right | Volume |
|---|---|---|---|---|
| 1 | Skin cancer vaccine FDA approved by December 31, 2027? | 72% | +38% | $19K |
Real-money prediction market · Trade with confidence
This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants approval of intismeran autogene for any indication by December 31, 2027, 11:59 PM ET. Otherwise, this market wil...
This prediction market tracks whether FDA approves skin cancer vaccine by December 31, 2027? will occur, with $19K in total trading volume reflecting significant trader interest. Prediction markets aggregate the collective intelligence of participants who stake real money on outcomes, making them one of the most reliable forecasting tools available for events driven by available information and market participant behavior.
Traders lean toward Skin cancer vaccine FDA approved by December 31, 2027? at 72%, suggesting a probable but not certain outcome. This moderate confidence level often reflects genuine uncertainty — markets at this range tend to see the most price movement as new information emerges.
Trading activity is exceptionally high, with $19K traded in the last 24 hours alone (100% of total volume). This surge often indicates breaking news, a key deadline approaching, or a significant shift in market sentiment.
This market is scheduled to resolve by 2027-12-31. As the resolution date approaches, expect increased trading activity and tighter probability estimates. Historical data shows that prediction market accuracy improves significantly in the final days before resolution.
As of Aug 20, 2026 at 00:05 UTC, the leading outcome is Skin cancer vaccine FDA approved by December 31, 2027? at 72% probability, with $19K in total trading volume on Polymarket.
What Are Prediction Markets? · How to Trade · Odds Calculator · Compare Platforms